Page 5 - Lipocine Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lipocine (NASDAQ:LPCN) Earns Sell Rating from Analysts at StockNews com

StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note released on Sunday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance Shares of NASDAQ LPCN opened at $2.51 on Friday. The company has a 50-day moving average price of $2.81 and a […]

Millennium managementLipocine incTopco ltdGoldman sachs group incLipocine company profileRenaissance technologiesEp wealth advisorsFree reportSachs groupGet free reportLipocine dailyNasdaq lpcnInitiated coverageStocknews com

Lipocine (NASDAQ:LPCN) Research Coverage Started at StockNews com

Lipocine (NASDAQ:LPCN) Research Coverage Started at StockNews com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Lipocine incTopco ltdEp wealth advisorsRenaissance technologiesMillennium managementGoldman sachs group incFree reportSachs groupGet free reportLipocine daily

Lipocine (NASDAQ:LPCN) Now Covered by Analysts at StockNews com

StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research report released on Saturday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance Shares of Lipocine stock opened at $2.79 on Friday. The stock has a 50-day moving average price of $3.66 and a […]

Topco ltdMillennium managementLipocine incGoldman sachs group incRenaissance technologiesFree reportGet free reportSachs groupState street corpStreet corpLipocine dailyNasdaq lpcnInitiated coverageStocknews com

StockNews com Begins Coverage on Lipocine (NASDAQ:LPCN)

StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a report published on Friday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance Lipocine stock opened at $2.96 on Friday. The company has a market cap of $15.75 million, a price-to-earnings ratio of -1.24 and a […]

Millennium managementBlackrock incGoldman sachs group incRenaissance technologiesLipocine incFree reportGet free reportStreet corpSachs groupLipocine dailyNasdaq lpcnInitiated coverageStocknews com

Lipocine (NASDAQ:LPCN) Now Covered by Analysts at StockNews com

StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note issued to investors on Thursday. The firm issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Up 5.3 % Shares of Lipocine stock opened at $2.98 on Thursday. The stock’s 50-day simple moving average is $4.13 and […]

Renaissance technologiesBlackrock incLipocine incGoldman sachs group incEp wealth advisorsMillennium managementLipocine company profileFree reportGet free reportGoldman sachs groupSachs groupLipocine dailyNasdaq lpcnInitiated coverageStocknews com